David has over 10 years’ experience as a strategy consultant to the life sciences and public health sectors specialising in R&D strategy, public-private biomedical research partnership design, and real-world patient data-enabled insight platforms to inform strategic decision-making. He has a keen interest in helping clients in their mission to discover and develop the next generation of innovative medical therapies and diagnostics and get these into the hands of clinicians and patients as fast and sustainably as possible.
He holds a Doctorate in oncology translational sciences from the University of Cambridge and has published peer-reviewed papers on a range of topics including survivorship outcomes for lung cancer, and efficacy of COVID-19 vaccination and testing regimes.